Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer
Timothy M. Zagar, Zeljko Vujaskovic, Silvia Formenti, Hope Rugo, Franco Muggia, Brigid O'Connor, Robert Myerson, Paul Stauffer, I. Chow Hsu, Chris Diederich, William Straube, Mary Keara Boss, Alina Boico, Oana Craciunescu, Paolo Maccarini, David Needham, Nicholas Borys, Kimberly L. Blackwell, Mark W. Dewhirst
Dive into the research topics of 'Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer'. Together they form a unique fingerprint.